Izenwasser S, Coy A E, Ladenheim B, Loeloff R J, Cadet J L, French D
Psychobiology Section, National Institute on Drug Abuse, Division of Intramural Research, Baltimore, MD 21224, USA.
Eur J Pharmacol. 1999 Jun 4;373(2-3):187-93. doi: 10.1016/s0014-2999(99)00274-5.
Continuous infusion of cocaine produces partial behavioral tolerance to its locomotor activating effects, while daily injections produce sensitization. Methylphenidate binds with a similar affinity to cocaine at the dopamine transporter, but has a much lower affinity for the serotonin transporter than does cocaine. This study was done to compare the effects of chronic methylphenidate with chronic cocaine. The pattern of locomotor activity over a 7 day treatment period was significantly different from cocaine. Methylphenidate elevated activity on each day, compared to saline, yet neither tolerance to a continuous infusion of the drug, nor sensitization to repeated daily injections was produced. We have previously shown that neither of these treatments with cocaine produces significant alterations in dopamine transporter density 1 day after the end of treatment. In contrast, methylphenidate injections significantly decreased dopamine transporters in rostral caudate putamen, with no change in nucleus accumbens. Continuous infusion of methylphenidate had no effect on dopamine transporters in either brain region. These findings provide further evidence that different classes of dopamine uptake inhibitors may interact with the dopamine transporter in qualitatively different manners. Furthermore, it is possible that the inhibition of serotonin uptake by cocaine may contribute to the adaptations in behavioral activity that are seen during chronic treatment.
持续输注可卡因会使其对运动激活作用产生部分行为耐受性,而每日注射则会导致敏化。哌甲酯在多巴胺转运体上与可卡因具有相似的亲和力,但对5-羟色胺转运体的亲和力远低于可卡因。本研究旨在比较慢性给予哌甲酯与慢性给予可卡因的效果。在为期7天的治疗期间,运动活动模式与可卡因显著不同。与生理盐水相比,哌甲酯每天都会提高活动水平,但既未产生对持续输注该药物的耐受性,也未对每日重复注射产生敏化。我们之前已经表明,在治疗结束1天后,这两种可卡因治疗方法均未使多巴胺转运体密度发生显著改变。相比之下,注射哌甲酯会使尾状核壳前部的多巴胺转运体显著减少,伏隔核则无变化。持续输注哌甲酯对这两个脑区的多巴胺转运体均无影响。这些发现进一步证明,不同类别的多巴胺摄取抑制剂可能以质的不同方式与多巴胺转运体相互作用。此外,可卡因对5-羟色胺摄取的抑制作用可能促成了慢性治疗期间所见的行为活动适应性变化。